Search
for
Sort by
Research 451–480 of 1000+
- Cytokines
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Food Habits, Daily Routine and Hair Loss — A Focused Review
- “Case Report : Early Congenital Syphilis”
- A partially automated method for DNA extraction from marmoset hair follicles to avoid blood chimerism
- POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- Détection précoce de la cardiotoxicité due à la doxorubicine chez le miniporc par imagerie par résonance magnétique
- Mucocutaneous reactions to chemotherapy
- Transforming growth factor-β in stem cells and tissue homeostasis
- Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Cutaneous complications of chemotherapeutic agents
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Interferon in the treatment of cutaneous T-cell lymphoma
- Physiologic functions of PP2A: Lessons from genetically modified mice
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Anagen effluvium
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Graft-versus-host disease
- Skin Manifestations in Primary Immunodeficient Children
- Hair disorders in patients with cancer
- TOXIC EPIDERMAL NECROLYSIS